Species differences in histomorphometry

Size: px
Start display at page:

Download "Species differences in histomorphometry"

Transcription

1 Species differences in histomorphometry Reinhold G. Erben Department of Biomedical Sciences Institute of Physiology and Pathophysiology University of Veterinary Medicine Vienna

2 Purpose of histomorphometry Histomorphometry is always related to mechanistic questions or safety issues Bone structure Bone formation Bone resorption Bone mineralization Bone modeling and remodeling

3 Important issues Strain-, gender-, age-related and site specific differences in bone structure and bone mass Differences in osteoclast morphology Differences in osteoblast morphology and assessment of bone formation Differences in cancellous and cortical bone remodeling Differences in the physiologic response to bone-active drugs

4 Gender-related differences in mice Female Female Male Male Estrogen is a bone anabolic hormone in mice, unlike other mammalian species. Schmidt et al. Am J Pathol 155:557, 1999

5 Age-related changes in mice 3 mo 3 mo 1 y

6 Age-related changes in rats 4 mo 2 2 y yorx

7 Vertebrae in mice and rats 3 mo 10 mo 22-mo-old rats SHAM ORX

8 Example: Efficacy of denosumab in GIO model Murine RANKL genomic structure Exon non-coding region RANKL targeting vector Human Ex 5 Neo Short arm Long arm LoxP LoxP TK TK Mu 3 non-coding region hurankl Knock-in allele Human Ex 5 Neo LoxP LoxP Exon Mu 3 non-coding region (Kostenuik et al., JBMR 24:182, 2009)

9 OPG/RANKL system RANK: Receptor activator of NFκB OPG: Osteoprotegerin RANKL: RANK ligand Stromal cell/t cell Oc precursor srankl RANK Denosumab Osteoclast Differentiation Fusion RANKL Denosumab OPG Osteoblasts/Stromal cells

10 Example: Efficacy of denosumab in GIO model 0.3 Bone formation rate L1 125 Serum osteocalcin (µm²/µm/day) (ng/ml) C Pred WT PBS Ab Control PBS Pred hrankl KI Ab Two-way ANOVA Effect of Pred: NS Effect of Denosumab: p< C WT Pred PBS Ab Control PBS Pred hrankl KI Ab Two-way ANOVA Effect of Pred: NS Effect of Denosumab: p=0.012 Hofbauer et al. Arthritis Rheum 60:1427, 2009

11 Example: Efficacy of denosumab in GIO model Bone formation rate distal femur (µm²/µm/day) PBS Ab PBS Ab C Pred Control WT Pred hrankl KI Two-way ANOVA Effect of Pred: NS Effect of Denosumab: p<0.001 In aged mice or severely osteopenic rats, always take out the verts! Hofbauer et al. Arthritis Rheum 60:1427, 2009

12 Differences in osteoclast morphology

13 Differences in osteoclast morphology Reliable detection of osteoclasts in mice should be based on TRAPstained sections! Therefore, it is necessary to use a methylmethacrylate mixture suitable for histochemistry (e.g., Erben, J Histochem Cytochem 45:307,1997), or to decalcify bone specimens.

14 Differences in osteoblast morphology Marker interval (cancellous bone formation!) 1 day in 3 4-wk-old mice 2 days in 8 12-wk-old mice 2-3 days in aged mice >5 mo 4-5 days in rats

15 Do mice and rats have bone remodeling? Rabbit Rat Mouse Gefäßkanal

16 Do rats and mice have bone remodeling?

17 Age dependent changes in modeling and remodeling Proximal tibial cancellous bone % of all formation sites months 6 months 9 months 12 months Age %Remodeling %Modeling %Uncertain (Erben 1996) Erben Anat Rec 246:39, 1996

18 Age dependent changes in modeling and remodeling Lumbar vertebral cancellous bone % of all formation sites months 6 months 12 months Age %Remodeling %Modeling %Uncertain (Erben, 1996) Erben Anat Rec 246:39, 1996

19 Age dependent changes in modeling and remodeling Longitudinal bone growth in the proximal tibia and L1 of female Fischer rats µm/day Proximal tibia L1, cranial growth plate L1, caudal growth plate months 6 months 9 months 12 months Age Erben Anat Rec 246:39, 1996

20 Labeling escape error MI1 MI2 To minimize the labeling escape error, the marker interval should be less than about 1/5 of the formation period. Time MI3 More information: Erben RG (2003) Bone Labeling Techniques. In: Handbook of Histology Methods for Bone and Cartilage. An YH, Martin KL (eds) Humana Press Inc., Totowa, NJ, USA, pp

21 Bone remodeling in rats and mice Rat vertebral cancellous bone FP RsP RmP (days) months 6 months 9 months 12 months Age

22 Bone remodeling in rats and mice Murine vertebral cancellous bone FP RsP RmP (days) months 6 months 9 months 12 months Age

23 Differences in physiological response to drugs (mg/cm³) Total BMD L4 * P<0.05 vs. Veh * Veh PTH Veh PTH Male Female Gender-related skeletal effect of cyclosporin A (ng/ml) Erben et al. Endocrinology 144:40, CsA blood concentration 800 Males Females SHAM GX GX+HRT Female rats have a 7-fold higher hepatic CsA excretion rate relative to males in steady state.

24 Betacellulin transgenic mice Male Female 3 wk 6 wk 9 wk 3 wk 6 wk 9 wk wt tg Schneider et al. JBMR 24:455, 2009

25 Take home messages Always take out vertebrae in aged mice and severely osteopenic rats. For the quantification of osteoclasts in mice always use TRAP staining. For the assessment of bone formation fluorochrome labeling with an appropriate marker interval is essential. Rats and mice lack true Haversian cortical bone remodeling, but not cancellous bone remodeling activity. Consider species specific effects of certain drugs in rats and mice (e.g., CsA in rats, estrogen and PTH in mice).

26 Acknowledgements Institute of Physiology & Pathophysiology University of Veterinary Medicine Vienna Ute Zeitz Claudia Bergow Christiane Schüler Kerstin Klien Institute of Animal Physiology LMU Munich Karin Begsteiger Sieglinde Hirmer Technical University Dresden Lorenz Hofbauer Gene Center LMU Munich Marlon Schneider Eckhard Wolf

27 ISBM Meeting, Zell am See, Austria, May 28 30, 2009 Special feature: One-day hands-on practical training course on May 28

Assessment and Treatment of Osteoporosis Professor T.Masud

Assessment and Treatment of Osteoporosis Professor T.Masud Assessment and Treatment of Osteoporosis Professor T.Masud Nottingham University Hospitals NHS Trust University of Nottingham University of Derby University of Southern Denmark What is Osteoporosis? Osteoporosis

More information

HRT and Risedronate Combined Anabolic and Antiresorptive Therapy

HRT and Risedronate Combined Anabolic and Antiresorptive Therapy Optimizing Combined and Sequential Osteoanabolic and Antiresorptive Therapy Benjamin Leder, M.D. Endocrine Unit Massachusetts General Hospital Boston, MA Antiresorptive and Osteoanabolic Therapies Increase

More information

Bone Cell Biology. David W. Dempster, PhD. Professor of Clinical Pathology Columbia University. Bone Remodeling

Bone Cell Biology. David W. Dempster, PhD. Professor of Clinical Pathology Columbia University. Bone Remodeling Bone Cell Biology David W. Dempster, PhD Professor of Clinical Pathology Columbia University Bone Remodeling The skeleton, out of site and often out of mind, is a formidable mass of tissue occupying about

More information

Bone Cell Biology. The Remodeling Cycle. Bone Remodeling. Remodeling Maintains Mechanical Strength. David W. Dempster, PhD

Bone Cell Biology. The Remodeling Cycle. Bone Remodeling. Remodeling Maintains Mechanical Strength. David W. Dempster, PhD Bone Remodeling Bone Cell Biology David W. Dempster, PhD Professor of Clinical Pathology Columbia University The skeleton, out of site and often out of mind, is a formidable mass of tissue occupying about

More information

OSTEONECROSI DEI MASCELLARI (ONJ): PREVENZIONE, DIAGNOSI, TRATTAMENTO UPDATE 2010

OSTEONECROSI DEI MASCELLARI (ONJ): PREVENZIONE, DIAGNOSI, TRATTAMENTO UPDATE 2010 OSTEONECROSI DEI MASCELLARI (ONJ): PREVENZIONE, DIAGNOSI, TRATTAMENTO UPDATE 2010 Alessandria, 5 giugno 2010 Novità nel trattamento dell osteoporosi Stefania Boldini Francesco Bertoldo Dipartimento di

More information

7/5/2016. We need drugs that. Disclosures. New Osteoporosis Treatments. What we have today. Maintain or promote bone formation

7/5/2016. We need drugs that. Disclosures. New Osteoporosis Treatments. What we have today. Maintain or promote bone formation New Osteoporosis Treatments Disclosures Mary L. Bouxsein, PhD Department of Orthopedic Surgery Harvard Medical School, Boston, MA Advisory Board: Research funding: Merck, Eli Lilly, Radius Merck, Amgen

More information

8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview

8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview Disclosure Glucocorticoid induced osteoporosis: overlooked and undertreated? I have no financial disclosure relevant to this presentation Tasma Harindhanavudhi, MD Division of Diabetes and Endocrinology

More information

Osteoclast Culture Kit

Osteoclast Culture Kit K-ASSAY KAMIYA BIOMEDICAL COMPANY Osteoclast Culture Kit For the culture of Osteoclasts from precursor cells. Cat. No.: CC-107 Rat Osteoclast Precursor Cells, V-1 CC-109 Mouse Osteoclast Precursor Cells,

More information

Siglec-15 Is A Potential Therapeutic Target For Postmenopausal Osteoporosis

Siglec-15 Is A Potential Therapeutic Target For Postmenopausal Osteoporosis Siglec-15 Is A Potential Therapeutic Target For Postmenopausal Osteoporosis Yusuke Kameda, Masahiko Takahata, Tomohiro Shimizu, Hiroki Hamano, Norimasa Iwasaki. Department of Orthopedic Surgery, Hokkaido

More information

Effects of Anti RANK ligand Denosumab on Beta Thalassemia induced osteoporosis

Effects of Anti RANK ligand Denosumab on Beta Thalassemia induced osteoporosis Effects of Anti RANK ligand Denosumab on Beta Thalassemia induced osteoporosis Mohamed Yassin 1 Ashraf T. Soliman2, Mohamed O. Abdelrahman3, Vincenzo De Sanctis 4 Departments of, 1 Hematology 2Pediatric

More information

New Agents for Myeloma Bone Disease

New Agents for Myeloma Bone Disease New Agents for Myeloma Bone Disease G. David Roodman MD PhD University of Pittsburgh Bone Remodeling is Uncoupled in Myeloma Normal Myeloma Hattner R et al. Nature. 1965;206:489. 1 Myeloma Bone Disease

More information

How cancellous and cortical bones adapt to loading and growth hormone

How cancellous and cortical bones adapt to loading and growth hormone J Musculoskel Neuron Interact 2000; 1:19-23 Review Article Hylonome How cancellous and cortical bones adapt to loading and growth hormone D.N. Kalu, J. Banu, L. Wang Department of Physiology, The University

More information

Fig. S1 A. week 4 week 6

Fig. S1 A. week 4 week 6 Fig. S1 Trabecular Number Trabecular Thickness number/mm 3.5 3. 2.5 2. 1.5 1..5 mm.45.4.35.3.25.2.15.1.5 SKG-c SKG-A mm 1.4 1.2 1..8.6.4.2 Trabecular Spacing D. week 4 week 6 Figure S1. MicroCT analysis

More information

Nature Medicine: doi: /nm.4324

Nature Medicine: doi: /nm.4324 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Supplementary Figure 1. Kinetics of SnCs development in surgically-induced OA and effect of GCV-induced SnC clearance on OA disease progression

More information

SpongeBone Menopants*

SpongeBone Menopants* SpongeBone Menopants* Adam Fershko, MD, FACP Kettering Health Network *Postmenopausal Osteoporosis Objectives O Epidemiology O Clinical significance O Pathophysiology O Screening and Diagnosis O Treatment

More information

NEW HORIZONS IN OSTEOPOROSIS THERAPY. Sundeep Khosla, M.D. Mayo Clinic, Rochester, MN

NEW HORIZONS IN OSTEOPOROSIS THERAPY. Sundeep Khosla, M.D. Mayo Clinic, Rochester, MN NEW HORIZONS IN OSTEOPOROSIS THERAPY Sundeep Khosla, M.D. Mayo Clinic, Rochester, MN DISCLOSURES SUNDEEP KHOSLA, M.D. Investigator-initiated grant Merck No non-fda approved recommendations RISK ASSESSMENT

More information

Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats

Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats SUPPLEMENTAL DATA Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats 1 Kerstin Stemmer, 2 Maximilian Bielohuby, 3 Bernadette E. Grayson, 3 Denovan P.

More information

Outline. Estrogens and SERMS The forgotten few! How Does Estrogen Work in Bone? Its Complex!!! 6/14/2013

Outline. Estrogens and SERMS The forgotten few! How Does Estrogen Work in Bone? Its Complex!!! 6/14/2013 Outline Estrogens and SERMS The forgotten few! Clifford J Rosen MD rosenc@mmc.org Physiology of Estrogen and estrogen receptors Actions of estrogen on bone BMD, fracture, other off target effects Cohort

More information

Pathophysiology of Postmenopausal & Glucocorticoid Induced Osteoporosis. March 15, 2016 Bone ECHO Kate T Queen, MD

Pathophysiology of Postmenopausal & Glucocorticoid Induced Osteoporosis. March 15, 2016 Bone ECHO Kate T Queen, MD Pathophysiology of Postmenopausal & Glucocorticoid Induced Osteoporosis March 15, 2016 Bone ECHO Kate T Queen, MD Review: normal bone formation Bone Modeling Remodeling Peak Bone Mass Maximum bone mass

More information

Presenter: 翁家嫻 Venue date:

Presenter: 翁家嫻 Venue date: FOR THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AT INCREASED RISK OF FRACTURES 1 Presenter: 翁家嫻 Venue date: 2018.03.13 PMO: postmenopausal osteoporosis. 1. Prolia (denosumab), Summary of Product

More information

Disclosures CONSULTANT WRIGHT MEDICAL CONSULTANT ORTHO FIX

Disclosures CONSULTANT WRIGHT MEDICAL CONSULTANT ORTHO FIX Disclosures CONSULTANT WRIGHT MEDICAL CONSULTANT ORTHO FIX Overview Radiographic Pattern Histopathology Pathways: RANKL/OPG AGE/RAGE Treatment based on Evidence Radiographic Pattern Pattern of Diabetic

More information

Osteoporosis Update. Greg Summers Consultant Rheumatologist

Osteoporosis Update. Greg Summers Consultant Rheumatologist Osteoporosis Update Greg Summers Consultant Rheumatologist DEFINITION OSTEOPOROSIS is LOW BONE MASS (& micro-architectural deterioration) causing AN INCREASED RISK OF FRACTURE 23 years 82 years 23 y/o

More information

PART FOUR. Metabolism and Nutrition

PART FOUR. Metabolism and Nutrition PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 21, 2005 Maria Mesquita, 1 Eric Wittersheim, 2 Anne Demulder, 2 Max Dratwa, 1 Pierre Bergmann 3 Bone Cytokines and Renal Osteodystrophy

More information

TEAM SCIENCE AT A PROGRAMMATIC LEVEL. Sundeep Khosla, M.D. Mayo Clinic College of Medicine

TEAM SCIENCE AT A PROGRAMMATIC LEVEL. Sundeep Khosla, M.D. Mayo Clinic College of Medicine TEAM SCIENCE AT A PROGRAMMATIC LEVEL Sundeep Khosla, M.D. Mayo Clinic College of Medicine APPROACH TO TRANSLATIONAL RESEARCH IN OSTEOPOROSIS Epidemiological Studies Clinical Investigation Mouse and Cellular

More information

Modélisation par éléments finis des effets des médicaments sur le remodelage osseux : Approche mécanobiologique

Modélisation par éléments finis des effets des médicaments sur le remodelage osseux : Approche mécanobiologique Modélisation par éléments finis des effets des médicaments sur le remodelage osseux : Approche mécanobiologique Ridha Hambli Prisme Institute 8, Rue Léonard de Vinci, 45072 Orléans cedex 2, France Phone

More information

Osteoporosis update. Dr. Claire Vandevelde Consultant Rheumatologist, LTHT

Osteoporosis update. Dr. Claire Vandevelde Consultant Rheumatologist, LTHT Osteoporosis update Dr. Claire Vandevelde Consultant Rheumatologist, LTHT Outline Background BMD Tools for assessing fracture risk Case study Denosumab Treatment breaks BMD BMD predicts fracture risk but

More information

Monitoring Osteoporosis Therapy

Monitoring Osteoporosis Therapy Monitoring Osteoporosis Therapy SUZANNE MORIN DEPT OF MEDICINE, DIVISION OF GENERAL INTERNAL MEDICINE, MUHC CENTRE FOR OUTCOMES RESEARCH AND EVALUATION, RI MUHC November 2017 Conflict of Interest Disclosures

More information

Upcoming Agents for Osteoporosis

Upcoming Agents for Osteoporosis Upcoming Agents for Osteoporosis May 5, 2017 Michael R. McClung, MD, FACP Director, Oregon Osteoporosis Center Portland, Oregon, USA Professorial Fellow, Institute of Health and Ageing Australian Catholic

More information

Icd 10 code metastatic bone disease

Icd 10 code metastatic bone disease Secondary malignant neoplasm of bone and bone marrow. Approximate Synonyms. Cancer metastatic to bone marrow. Clinical Information. Cancer that has spread from the original (primary) tumor to the bone

More information

THE GROWING GAP IN OSTEOPOROSIS TREATMENT

THE GROWING GAP IN OSTEOPOROSIS TREATMENT THE GROWING GAP IN OSTEOPOROSIS TREATMENT Sundeep Khosla, M.D. Mayo Clinic, Rochester, MN DISCLOSURES SUNDEEP KHOSLA, M.D. NONE 1 OVERALL CONCLUSIONS There has been remarkable progress in our understanding

More information

Hierarchical Microimaging of Bone Structure and Function

Hierarchical Microimaging of Bone Structure and Function Hierarchical Microimaging of Bone Structure and Function Prof. Ralph Müller, PhD Institute for Biomechanics, ETH Zürich, Zürich, Switzerland 1 Motivation and aims Engineering endpoints have become an important

More information

An Update on Osteoporosis Treatments

An Update on Osteoporosis Treatments An Update on Osteoporosis Treatments Dr Mike Stone University Hospital Llandough Treatments for osteoporosis Calcium and vitamin D HRT Raloxifene Etidronate Alendronate Risedronate Ibandronate (oral and

More information

ANATOMY C027A: MINERALIZED TISSUE BIOLOGY: SKELETAL TISSUES. Please answer THREE Questions. All questions carry equal marks.

ANATOMY C027A: MINERALIZED TISSUE BIOLOGY: SKELETAL TISSUES. Please answer THREE Questions. All questions carry equal marks. Module Code: C27A UNIVERSITY OF LONDON (University College London) BSc DEGREE 2001 ANATOMY C027A: MINERALIZED TISSUE BIOLOGY: SKELETAL TISSUES 16 May 2001, 10.00am 1) Discuss the roles of ph, po2, phosphate

More information

Opg/Rankl mrna dynamic expression in the bone tissue of ovariectomized rats with osteoporosis

Opg/Rankl mrna dynamic expression in the bone tissue of ovariectomized rats with osteoporosis Opg/Rankl mrna dynamic expression in the bone tissue of ovariectomized rats with osteoporosis C.W. Li 1 *, B. Liang 2 *, X.L. Shi 3 and H. Wang 3 * 1 Zhejiang Chinese Medical University, Hangzhou, China

More information

Rama Nada. - Mousa Al-Abbadi. 1 P a g e

Rama Nada. - Mousa Al-Abbadi. 1 P a g e - 1 - Rama Nada - - Mousa Al-Abbadi 1 P a g e Bones, Joints and Soft tissue tumors Before we start: the first 8 minutes was recalling to Dr.Mousa s duties, go over them in the slides. Wherever you see

More information

Osteoporosis - Pathophysiology and diagnosis. Bente L Langdahl Department of Endocrinology Aarhus University Hospital Aarhus, Denmark

Osteoporosis - Pathophysiology and diagnosis. Bente L Langdahl Department of Endocrinology Aarhus University Hospital Aarhus, Denmark Osteoporosis - Pathophysiology and diagnosis Bente L Langdahl Department of Endocrinology Aarhus University Hospital Aarhus, Denmark Objective General knowledge about osteoporosis Optimise your protocols

More information

Supplemental figures and figure legends (90517-INS-RG-RV-2) Supplemental Figure 1.

Supplemental figures and figure legends (90517-INS-RG-RV-2) Supplemental Figure 1. Supplemental figures and figure legends (957-INS-RG-RV-) Supplemental Figure. A B.5.5 Interaction p=.89 Model p

More information

TITLE: Effect of a High Bone Turnover State Induced by Estrogen Deficiency on the Development and Progression of Breast Cancer Bone Metastases

TITLE: Effect of a High Bone Turnover State Induced by Estrogen Deficiency on the Development and Progression of Breast Cancer Bone Metastases AD AWARD NUMBER: W81XWH-5-1-311 TITLE: Effect of a High Bone Turnover State Induced by Estrogen Deficiency on the Development and Progression of Breast Cancer Bone Metastases PRINCIPAL INVESTIGATOR: Wende

More information

BONE HISTOLOGY SLIDE PRESENTATION

BONE HISTOLOGY SLIDE PRESENTATION BONE HISTOLOGY SLIDE PRESENTATION PRESENTED BY: SKELETECH, INC. Clients and Friends: SkeleTech invites you to use these complimentary images for your own presentations or as teaching slides for bone biology.

More information

Osteoclast Culture Kit

Osteoclast Culture Kit K-ASSAY Osteoclast Culture Kit For the culture of Osteoclasts from precursor cells. Cat. No.: CC-107 Rat Osteoclast Precursor Cells, V-1 For Research Use Only. 1 Rev. 091708 K-ASSAY PRODUCT INFORMATION

More information

New Therapeutic Directions: Osteoanabolic and Antiresorptive Therapy in Combination Therapy and in Sequence

New Therapeutic Directions: Osteoanabolic and Antiresorptive Therapy in Combination Therapy and in Sequence New Therapeutic Directions: Osteoanabolic and Antiresorptive Therapy in Combination Therapy and in Sequence John P. Bilezikian, MD, PhD(hon), MACE Silberberg Professor of Medicine Vice-Chair for International

More information

Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism

Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism European Journal of Endocrinology (1999) 141 195 210 ISSN 0804-4643 REVIEW Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism Lorenz C Hofbauer Division

More information

Estrogen receptor α- (ERα), but not ERβ-signaling, is crucially involved in mechanostimulation of bone fracture healing by whole-body vibration

Estrogen receptor α- (ERα), but not ERβ-signaling, is crucially involved in mechanostimulation of bone fracture healing by whole-body vibration Estrogen receptor α- (ERα), but not ERβ-signaling, is crucially involved in mechanostimulation of bone fracture healing by whole-body vibration Melanie Haffner-Luntzer et.al. published in BONE 1 Abstract

More information

Drugs Affecting Bone. Rosa McCarty PhD. Department of Pharmacology & Therapeutics

Drugs Affecting Bone. Rosa McCarty PhD. Department of Pharmacology & Therapeutics Drugs Affecting Bone Rosa McCarty PhD Department of Pharmacology & Therapeutics rmccarty@unimelb.edu.au Objectives At the end of this lecture you should have gained: An understanding of bone metabolism

More information

Anabolic Therapy With Teriparatide Indications Beyond Osteoporosis

Anabolic Therapy With Teriparatide Indications Beyond Osteoporosis Anabolic Therapy With Teriparatide Indications Beyond Osteoporosis Andreas Panagopoulos MD, PhD Upper Limb & Sports Medicine Orthopaedic Surgeon Assistant Professor, University of Patras Outline Teriparatide

More information

A KL/R / AN A K/O / P O G G

A KL/R / AN A K/O / P O G G Outline and New Treatments on the Horizon Steven R. Cummings, MD CPMC and UCSF San Francisco Coordinating Center Support from Lilly and Amgen New treatments, new mechanisms of action Cathepsin K inhibition

More information

A Novel Murine Model Of Adynamic Bone Disease (ABD)

A Novel Murine Model Of Adynamic Bone Disease (ABD) A Novel Murine Model Of Adynamic Bone Disease (ABD) Adeline H. Ng 1,2, Thomas L. Willett, PhD 2,1, Benjamin A. Alman 3,1, Marc D. Grynpas 1,2. 1 University of Toronto, Toronto, ON, Canada, 2 Samuel Lunenfeld

More information

Osteoporosis 2017 Breaking News. Julie L. Carkin, MD The Seattle Arthritis Clinic

Osteoporosis 2017 Breaking News. Julie L. Carkin, MD The Seattle Arthritis Clinic Osteoporosis 2017 Breaking News Julie L. Carkin, MD The Seattle Arthritis Clinic 1 Yes, Hopefully & No Anabolic Teriparatide Abaloparatide Romosozumab blosozumab Anti-catabolic Bisphosphonates Denosumab

More information

Supplementary Material for

Supplementary Material for Supplementary Material for Parathyroid Hormone Signaling through Low-density-lipoprotein-related Protein 6 Mei Wan, Chaozhe Yang, Jun Li, Xiangwei Wu, Hongling Yuan, Hairong Ma, Xi He, Shuyi Nie, Chenbei

More information

Awaisheh. Mousa Al-Abbadi. Abdullah Alaraj. 1 Page

Awaisheh. Mousa Al-Abbadi. Abdullah Alaraj. 1 Page f #3 Awaisheh Abdullah Alaraj Mousa Al-Abbadi 1 Page *This sheet was written from Section 1 s lecture, in the first 10 mins the Dr. repeated all the previous material relating to osteoporosis from the

More information

Figure 1. Dnmt3b expression in murine and human knee joint cartilage. (A) Representative images

Figure 1. Dnmt3b expression in murine and human knee joint cartilage. (A) Representative images Figure Legends Figure. expression in murine and human knee joint cartilage. () Representative images showing that Dnmta is not expressed in chondrocytes from mo W articular cartilage [Dnmta expression

More information

BONE REMODELLING. Tim Arnett. University College London. Department of Anatomy and Developmental Biology

BONE REMODELLING. Tim Arnett. University College London. Department of Anatomy and Developmental Biology BONE REMODELLING Tim Arnett Department of Anatomy and Developmental Biology University College London The skeleton, out of sight and often out of mind, is a formidable mass of tissue occupying about 9%

More information

Osteoporosis: current treatment and future prospects. Juliet Compston Professor Emeritus of Bone Medicine Cambridge Biomedical Campus

Osteoporosis: current treatment and future prospects. Juliet Compston Professor Emeritus of Bone Medicine Cambridge Biomedical Campus Osteoporosis: current treatment and future prospects Juliet Compston Professor Emeritus of Bone Medicine Cambridge Biomedical Campus Disclosures Consultancy and speaking fees for Gilead, related to development

More information

What is Osteoporosis?

What is Osteoporosis? What is Osteoporosis? 2000 NIH Definition A skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture. Bone strength reflects the integration of

More information

Introduction to Biomedical Engineering: Basic concepts and Bone Biomechanics

Introduction to Biomedical Engineering: Basic concepts and Bone Biomechanics Introduction to Biomedical Engineering: Basic concepts and Bone Biomechanics Fall 2016, AKUT G. Rouhi Biomechanics The field of biomechanics applies principles of mechanics to study the structure and function

More information

Bone and Cancer. Peter Croucher

Bone and Cancer. Peter Croucher Bone and Cancer Peter Croucher Academic Unit of Bone Biology, Section of Musculoskeletal Science, University of Sheffield Medical School, Sheffield, UK Learning Objectives To Develop Understanding of:

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Prolia 60 mg solution for injection in a pre-filled syringe 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe

More information

The purpose of this practical session is to demonstrate cartilage and bone as specialized connective tissues to the student.

The purpose of this practical session is to demonstrate cartilage and bone as specialized connective tissues to the student. 1 CARTILAGE AND BONE The purpose of this practical session is to demonstrate cartilage and bone as specialized connective tissues to the student. 1. Hyaline cartilage Slide 73 This is a cross section through

More information

Current and Emerging Strategies for Osteoporosis

Current and Emerging Strategies for Osteoporosis Current and Emerging Strategies for Osteoporosis I have nothing to disclose. Anne Schafer, MD Assistant Professor of Medicine Division of Endocrinology & Metabolism December 12, 2014 Outline Osteoporosis

More information

Lecture 3: Skeletogenesis and diseases

Lecture 3: Skeletogenesis and diseases Jilin University School of Stomatology Skeletogenesis Lecture 3: Skeletogenesis and diseases Aug. 21, 2015 Yuji Mishina, Ph.D. mishina@umich.edu Bone Development Mouse embryo, E14.5 Mouse embryo, E18.0

More information

Comment les cellules osseuses communiquent entre elles. Gérard Friedlander Journées UPA 2011

Comment les cellules osseuses communiquent entre elles. Gérard Friedlander Journées UPA 2011 Comment les cellules osseuses communiquent entre elles Gérard Friedlander Journées UPA 2011 Structure de l os Osteocyte Ostéoclaste Remodelage osseux RANKL RANK NF-kB pathway Stem cell progenitor precursor

More information

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Annual Rheumatology & Therapeutics Review for Organizations & Societies Annual Rheumatology & Therapeutics Review for Organizations & Societies Biochemical Markers of Bone Turnover: Definitions and Recommendations for Monitoring Therapy Learning Objectives for Biochemical

More information

Bone mechanics bone strength and beyond

Bone mechanics bone strength and beyond Bone mechanics bone strength and beyond Tim Arnett Bone Curriculum Symposium 2018 Department of Cell & Developmental Biology University College London Factors affecting bone strength Mass Architectural

More information

Osteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.

Osteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of. Osteoporosis When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of. Osteoblasts by definition are those cells present in the bone and are involved

More information

Mutation in Osteoactivin Enhances RANKL-Mediated Signaling, Promoting Osteoclast Differentiation, Survival and Inhibiting Bone Resorption

Mutation in Osteoactivin Enhances RANKL-Mediated Signaling, Promoting Osteoclast Differentiation, Survival and Inhibiting Bone Resorption Mutation in Osteoactivin Enhances RANKL-Mediated Signaling, Promoting Osteoclast Differentiation, Survival and Inhibiting Bone Resorption Samir Abdelmagid, MD, PhD, Fouad Moussa, BS, Sondag Gregory, MS,

More information

The Pathogenesis of Bone Erosions in RA FULL VERSION

The Pathogenesis of Bone Erosions in RA FULL VERSION The Pathogenesis of Bone Erosions in RA FULL VERSION 1 Key Learning Objectives Understand the role of osteoclasts in normal bone remodeling Comprehend the key processes in pathologic osteoclast functions

More information

Review Article Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis

Review Article Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis International Journal of Endocrinology, Article ID 235060, 25 pages http://dx.doi.org/10.1155/2014/235060 Review Article Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis Vittorio Locatelli 1 and

More information

Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis

Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis Handling editor Tore K Kvien 1 Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany 2 Department of Rheumatology, Renji Hospital, Shanghai, China 3 Amgen Inc., Thousand

More information

The Skeletal System. Chapter 7a. Skeletal System Introduction Functions of the skeleton Framework of bones The skeleton through life

The Skeletal System. Chapter 7a. Skeletal System Introduction Functions of the skeleton Framework of bones The skeleton through life The Skeletal System Skeletal System Introduction Functions of the skeleton Framework of bones The skeleton through life Chapter 7a Support Protection Movement Storage areas Minerals Lipids Hemopoiesis

More information

DISCLOSURES TOPICS" PATHOPHYSIOLOGY of OSTEOPOROSIS: Pathways That Control Bone Remodeling! Why Do Bones Remodel?" Nothing to disclose

DISCLOSURES TOPICS PATHOPHYSIOLOGY of OSTEOPOROSIS: Pathways That Control Bone Remodeling! Why Do Bones Remodel? Nothing to disclose PATHOPHYSIOLOGY of OSTEOPOROSIS: Pathways That Control Bone Remodeling Dolores Shoback, MD Professor of Medicine, UCSF Staff Physician SF/VAMC May 19, 2017 DISCLOSURES Nothing to disclose No conflicts

More information

Regulation of the skeletal mass through the life span

Regulation of the skeletal mass through the life span Regulation of the skeletal mass through the life span Functions of the skeletal system Mechanical protection skull Movement leverage for muscles Mineral metabolism calcium store Erythropoiesis red blood

More information

BONE TISSUE. Dr. Heba Kalbouneh Associate Professor of Anatomy and Histology

BONE TISSUE. Dr. Heba Kalbouneh Associate Professor of Anatomy and Histology BONE TISSUE Dr. Heba Kalbouneh Associate Professor of Anatomy and Histology BONE FUNCTION Support Protection (protect internal organs) Movement (provide leverage system for skeletal muscles, tendons, ligaments

More information

Supplementary data Supplementary Figure 1 Supplementary Figure 2

Supplementary data Supplementary Figure 1 Supplementary Figure 2 Supplementary data Supplementary Figure 1 SPHK1 sirna increases RANKL-induced osteoclastogenesis in RAW264.7 cell culture. (A) RAW264.7 cells were transfected with oligocassettes containing SPHK1 sirna

More information

Bio 103 Skeletal System 45

Bio 103 Skeletal System 45 45 Lecture Outline: SKELETAL SYSTEM [Chapters 7, 8] Introduction A. Components B. Functions 1. 2. 3. 4. Classification and Parts A. Bone Shapes 1. Long: 2. Short: 3. Flat: 4. Irregular: 5. Sesamoid: B.

More information

Mouse Glu-OC (undercarboxylated osteocalcin) and Gla-OC (carboxylated osteocalcin) levels were

Mouse Glu-OC (undercarboxylated osteocalcin) and Gla-OC (carboxylated osteocalcin) levels were Supplemental Data Supplemental Materials and Methods Plasma measurements Mouse Glu-OC (undercarboxylated osteocalcin) and Gla-OC (carboxylated osteocalcin) levels were determined using ELISA kits according

More information

Differentiating Pharmacological Therapies for Osteoporosis

Differentiating Pharmacological Therapies for Osteoporosis Differentiating Pharmacological Therapies for Osteoporosis Socrates E Papapoulos Department of Endocrinology & Metabolic Diseases Leiden University Medical Center The Netherlands Competing interests: consulting/speaking

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION 1. Supplementary Figures and Legends Supplementary Fig. 1. S1P-mediated transcriptional regulation of integrins expressed in OP/monocytoid cells. Real-time quantitative PCR analyses of mrna for two integrins,

More information

Review Article RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis

Review Article RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis SAGE-Hindawi Access to Research Osteoporosis Volume 2011, Article ID 941310, 6 pages doi:10.4061/2011/941310 Review Article RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis

More information

Skeletal Tissues. Skeletal tissues. Frame; muscles, organs and CT attach. Brain, spinal cord, thoracic organs; heart and lungs.

Skeletal Tissues. Skeletal tissues. Frame; muscles, organs and CT attach. Brain, spinal cord, thoracic organs; heart and lungs. Skeletal Tissues Functions 1) support 2) protection 3) movement Skeletal tissues Frame; muscles, organs and CT attach. Brain, spinal cord, thoracic organs; heart and lungs. Aids muscle contraction; generate

More information

DENOSUMAB (PROLIA & XGEVA )

DENOSUMAB (PROLIA & XGEVA ) DENOSUMAB (PROLIA & XGEVA ) UnitedHealthcare Oxford Clinical Policy Policy Number: PHARMACY 306.3 T2 Effective Date: July 2, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE...

More information

Download slides:

Download slides: Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division

More information

Osteoporosis. Treatment of a Silently Developing Disease

Osteoporosis. Treatment of a Silently Developing Disease Osteoporosis Treatment of a Silently Developing Disease Marc K. Drezner, MD Senior Associate Dean Emeritus Professor of Medicine Emeritus University of Wisconsin-Madison Auditorium The Forest at Duke October

More information

Interactions between bone and the central nervous system Florent Elefteriou, PhD

Interactions between bone and the central nervous system Florent Elefteriou, PhD Interactions between bone and the central nervous system Florent Elefteriou, PhD Department of Medicine Center for Bone Biology VANDERBILT UNIVERSITY Nashville, USA BONE REMODELING Bone marrow cells Estrogen

More information

New treatments of osteoporosis

New treatments of osteoporosis HOSTED BY Available online at www.sciencedirect.com ScienceDirect Osteoporosis and Sarcopenia 1 (2015) 4e21 Review article New treatments of osteoporosis http://www.elsevier.com/locate/afos Bente L. Langdahl

More information

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS 4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending

More information

Imaging to Assess Bone Strength and its Determinants

Imaging to Assess Bone Strength and its Determinants Imaging to Assess Bone Strength and its Determinants Mary L. Bouxsein, PhD Harvard Medical School, Boston, MA UCSF Osteoporosis Course 26 July 212 Consultant / advisor: Amgen, Eli Lilly, Merck Research

More information

Index. Rheum Dis Clin N Am 32 (2006) Note: Page numbers of article titles are in boldface type.

Index. Rheum Dis Clin N Am 32 (2006) Note: Page numbers of article titles are in boldface type. Rheum Dis Clin N Am 32 (2006) 775 780 Index Note: Page numbers of article titles are in boldface type. A AACE (American Association of Clinical Endocrinologists), bone mineral density recommendations of,

More information

BIOLOGY and BIOMECHANICS OF NORMAL & OSTEOPOROTIC BONE

BIOLOGY and BIOMECHANICS OF NORMAL & OSTEOPOROTIC BONE BIOLOGY and BIOMECHANICS OF NORMAL & OSTEOPOROTIC BONE Andreas Panagopoulos, MD, PhD Assistant Professor in Orthopaedics University Hospital of Patras, Orthopaedic Clinic Objectives Bone structure and

More information

Osteocyte Wnt/ -Catenin Signaling Is Required for Normal Bone Homeostasis

Osteocyte Wnt/ -Catenin Signaling Is Required for Normal Bone Homeostasis MOLECULAR AND CELLULAR BIOLOGY, June 2010, p. 3071 3085 Vol. 30, No. 12 0270-7306/10/$12.00 doi:10.1128/mcb.01428-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Osteocyte Wnt/

More information

Effects of Whole Body Exposure to Electromagnetic Field on Normal and Osteoporotic Bone Metabolism in Rats

Effects of Whole Body Exposure to Electromagnetic Field on Normal and Osteoporotic Bone Metabolism in Rats Effects of Whole Body Exposure to tromagnetic Field on Normal and Osteoporotic Bone Metabolism in Rats S. Fukuda and H. Iida National Institute of Radiological Sciences, Chiba 263-8 Japan INTRODUCTION

More information

As the most common bone disease in

As the most common bone disease in AN UPDATE ON OSTEOPOROSIS EPIDEMIOLOGY AND BONE PHYSIOLOGY Elena M. Umland, PharmD* ABSTRACT Osteoporosis is a significant public health concern, affecting 10 million Americans over the age of 50 and causing

More information

The Skeletal System. Chapter 4

The Skeletal System. Chapter 4 The Skeletal System Chapter 4 FUNCTIONS OF THE SKELETAL SYSTEM Support o Provides shape Protection o Internal organs Movement o Provides structure for muscle to act upon Storage o Minerals & fat Blood

More information

TREATMENT OF OSTEOPOROSIS HOLIDAYS OR NO HOLIDAYS? Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO

TREATMENT OF OSTEOPOROSIS HOLIDAYS OR NO HOLIDAYS? Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO TREATMENT OF OSTEOPOROSIS HOLIDAYS OR NO HOLIDAYS? Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO DISCLOSURES Honoraria: Amgen, Merck, Shire Consulting : AbbVie, Amgen, Merck,

More information

Vol. 19, Bulletin No. 108 August-September 2012 Also in the Bulletin: Denosumab 120mg for Bone Metastases

Vol. 19, Bulletin No. 108 August-September 2012 Also in the Bulletin: Denosumab 120mg for Bone Metastases ה מ ר א פ הביטאון לענייני תרופות ISRAEL DRUG BULLETIN 19 years of unbiased and independent drug information P H A R x M A Vol. 19, Bulletin No. 108 August-September 2012 Also in the Bulletin: Denosumab

More information

Collagen Crosslinks, Any Method

Collagen Crosslinks, Any Method 190.19 - Collagen Crosslinks, Any Method Collagen crosslinks, part of the matrix of bone upon which bone mineral is deposited, are biochemical markers the excretion of which provides a quantitative measurement

More information

Osteoclasts- What Do They Do and How Do They Do It? Prof. Steven L. Teitelbaum

Osteoclasts- What Do They Do and How Do They Do It? Prof. Steven L. Teitelbaum Osteoclasts; What Do They Do 1 Steven L. Teitelbaum, M.D. Wilma and Roswell Messing Professor Department of Pathology and Immunology Washington University School of Medicine OSTEOCLASTS OSTEOBLASTS 2 Osteoclasts

More information

Collagen Crosslinks, Any Method

Collagen Crosslinks, Any Method 190.19 - Collagen Crosslinks, Any Method Collagen crosslinks, part of the matrix of bone upon which bone mineral is deposited, are biochemical markers the excretion of which provides a quantitative measurement

More information

denosumab (Prolia ) Policy # Original Effective Date: 07/21/2011 Current Effective Date: 04/19/2017

denosumab (Prolia ) Policy # Original Effective Date: 07/21/2011 Current Effective Date: 04/19/2017 Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information